Literature DB >> 10818441

Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors.

S Spiegel1.   

Abstract

Ample evidence indicates that sphingosine-1-phosphate (SPP) can serve as an intracellular second messenger regulating calcium mobilization, cell growth, and survival. Moreover, the dynamic balance between levels of the sphingolipids metabolites, ceramide, and SPP, and consequent regulation of opposing signaling pathways, is an important factor that determines whether a cell survives or dies. This ceramide/SPP rheostat is an evolutionarily conserved stress regulatory mechanism influencing growth and survival of yeast. In addition, SPP also has been identified as the ligand for the G-protein-coupled receptors EDG-1, -3, -5, and -6. Binding of SPP to EDG-1 regulates chemotaxis and in vitro angiogenesis of endothelial cells, whereas EDG-5, and possibly EDG-3, are likely the cell surface receptors responsible for cell rounding and neurite retractions induced by SPP. Hence, the studies identify a family of highly specific SPP receptors that are capable of mediating different biological responses. Thus, it is suggested that SPP is a prototype for a novel class of lipid mediators that act both extracellularly as ligands for cell surface receptors and intracellularly as second messengers. Recently, sphingosine kinase was purified to homogeneity and the first mammalian sphingosine kinase, the enzyme responsible for the formation of SPP, was cloned. The studies should provide the necessary tools to develop insight into the biological roles of this important bioactive sphingolipid.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818441     DOI: 10.1111/j.1749-6632.2000.tb06537.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  26 in total

Review 1.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

2.  Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist.

Authors:  Hugh Rosen; Christopher Alfonso; Charles D Surh; Michael G McHeyzer-Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

Review 3.  Discovery of fingolimod based on the chemical modification of a natural product from the fungus, Isaria sinclairii.

Authors:  Kenji Chiba
Journal:  J Antibiot (Tokyo)       Date:  2020-07-17       Impact factor: 2.649

Review 4.  Sphingosine-1-phosphate receptors and innate immunity.

Authors:  Arielle M Bryan; Maurizio Del Poeta
Journal:  Cell Microbiol       Date:  2018-03-23       Impact factor: 3.715

5.  Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation.

Authors:  Mihwa Kim; Minjae Kim; Sang Won Park; Stuart M Pitson; H Thomas Lee
Journal:  Am J Nephrol       Date:  2010-03-16       Impact factor: 3.754

6.  An obligate role for membrane-associated neutral sphingomyelinase activity in orienting chemotactic migration of human neutrophils.

Authors:  Robert G Sitrin; Timothy M Sassanella; Howard R Petty
Journal:  Am J Respir Cell Mol Biol       Date:  2010-04-08       Impact factor: 6.914

7.  Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages.

Authors:  Philipp Burow; Manuela Klapperstück; Fritz Markwardt
Journal:  Pflugers Arch       Date:  2014-06-26       Impact factor: 3.657

Review 8.  The alliance of sphingosine-1-phosphate and its receptors in immunity.

Authors:  Juan Rivera; Richard L Proia; Ana Olivera
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 9.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

10.  IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI.

Authors:  Joo Yun Kim; Mihwa Kim; Ahrom Ham; Kevin M Brown; Robert W Greene; Vivette D D'Agati; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.